TITLE

A tiered-layered-staged model for informed consent in personal genome testing

AUTHOR(S)
Bunnik, Eline M; Janssens, A Cecile J W; Schermer, Maartje H N
PUB. DATE
June 2013
SOURCE
European Journal of Human Genetics;Jun2013, Vol. 21 Issue 6, p596
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
In recent years, developments in genomics technologies have led to the rise of commercial personal genome testing (PGT): broad genome-wide testing for multiple diseases simultaneously. While some commercial providers require physicians to order a personal genome test, others can be accessed directly. All providers advertise directly to consumers and offer genetic risk information about dozens of diseases in one single purchase. The quantity and the complexity of risk information pose challenges to adequate pre-test and post-test information provision and informed consent. There are currently no guidelines for what should constitute informed consent in PGT or how adequate informed consent can be achieved. In this paper, we propose a tiered-layered-staged model for informed consent. First, the proposed model is tiered as it offers choices between categories of diseases that are associated with distinct ethical, personal or societal issues. Second, the model distinguishes layers of information with a first layer offering minimal, indispensable information that is material to all consumers, and additional layers offering more detailed information made available upon request. Finally, the model stages informed consent as a process by feeding information to consumers in each subsequent stage of the process of undergoing a test, and by accommodating renewed consent for test result updates, resulting from the ongoing development of the science underlying PGT. A tiered-layered-staged model for informed consent with a focus on the consumer perspective can help overcome the ethical problems of information provision and informed consent in direct-to-consumer PGT.
ACCESSION #
87598051

 

Related Articles

  • The right to ignorance. Aldhous, Peter // New Scientist;9/7/2013, Vol. 219 Issue 2933, p5 

    The article introduces a report within the issue about the use of whole-genome sequencing in screening for rare hereditary diseases, noting ethical concerns over the disclosure of evidence of potential disease risks to genome sequencing research subjects.

  • Valid consent for genomic epidemiology in developing countries. Chokshi, Dave A.; Thera, Mahamadou A.; Parker, Michael; Diakite, Mahamadou; Makani, Julie; Kwiatkowski, Dominic P.; Doumbo, Ogobara K. // PLoS Medicine;Apr2007, Vol. 4 Issue 4, pe95 

    Drawing on experience gained from ongoing research in Mali, this paper describes practical ethical challenges relating to the achievement of valid consent in genomic epidemiology.

  • Precision Medicine and the Changing Landscape of Research Ethics. Hammer, Marilyn J. // Oncology Nursing Forum;Mar2016, Vol. 43 Issue 2, p149 

    The article discusses the launch of the National Institutes of Health Precision Medicine Initiative® (PMI) by U.S. President Barack Obama aimed to individualized or personalized medicine through advances in science and technology such as genetics and genomics sequencing. It explores on the...

  • `Decoding' informed consent. Geller, Gail; Strauss, Misha // Hastings Center Report;Mar/Apr97, Vol. 27 Issue 2, p28 

    Discusses the moral and ethical aspects of informed consent in breast cancer diagnosis. Insights from consumers regarding informed consent; Role of provider recommendations; Challenges to the components and process of informed consent; Patient preferences with regard to the decision-making process.

  • Factoring ethnic and racial differences into bioethics decision making. Michel, Vicki // Generations;Winter94, Vol. 18 Issue 4, p23 

    Comments on the need for American caregivers to consider a patient's cultural and racial differences in viewing bioethical decision making. Concept of individual autonomous informed decision making; Recognition of the existence of cultural differences between the patient and the caregivers;...

  • A linguistic model of informed consent. Marta, Jan // Journal of Medicine & Philosophy;Feb96, Vol. 21 Issue 1, p41 

    Examines the disclosure model of informed consent which ignores the diversity of languages as relates to the communication between patient and doctor. Theories of J.L. Austin, Roman Jakobson and Mikhail Bakhtin on informed consent; Standard medico-legal model of informed consent; Conversational...

  • Consent and discontent. Wenger, Neil S.; Shapiro, Martin F. // CMAJ: Canadian Medical Association Journal;12/15/97, Vol. 157 Issue 12, p1691 

    Examines the status of research ethics and informed consent, as of December 15, 1997. Report of the United States Advisory Committee on Human Radiation Experiments regarding tests done without participants' consent; Protection levels for subjects; Cases of scientific misconduct; Impact of...

  • A commentary on `Informed consent to septoplasty: An anecdote from the field'. Erde, Edmund L. // Journal of Medicine & Philosophy;Feb99, Vol. 24 Issue 1, p18 

    Examines informed consent as recounted in the article `Informed consent to septoplasty: An anecdote from the field' in the United States. Moral and ethical aspects of informed consent; Elements of the content of informed consent; Lack of awareness among physicians on post-operative experience;...

  • Access to data sets is ethical concern.  // Medical Ethics Advisor;8/1/2012, p90 

    The article focuses on the potential ethical issues on the accession to data sets of blood donors, DNA or tissue samples. It mentions that individualized informed consent is essential before such samples could be utilized in subsequent research. However, it notes that the databanks could be less...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics